Global Metagenomics Sequencing

Metagenomics Sequencing Comprehensive Study by Application (Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biofuel, Others), Technology (Sequencing, Bioinformatics), Service (Reagents & Consumables, Metagenomics Sequencing Services, Analysis & Data Interpretation Solutions, Others), Workflow (Sample Processing & Library Preparation, Sequencing, Data Processing & Analysis) Players and Region - Global Market Outlook to 2030

Metagenomics Sequencing Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Metagenomics Sequencing Market Scope
Metagenomics is the study of a microbial community's genomes as a whole. Cloning and studying genomes without cultivating organisms in the community is part of this procedure. The metagenomics technique has resulted in significant improvements in microbial ecology, evolution, and diversity, this activity is currently mostly carried out in many research labs. The expansion of the worldwide metagenomics sequencing market is mostly fuelled by reasons such as major applications of metagenomics in many industries, numerous initiatives and financing from government and corporate organizations for large-scale sequencing projects, and a decrease in sequencing costs.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledIllumina, Inc. (United States), Thermo Fisher Scientific (United States), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (United States), Oxford Nanopore Technologies Plc. (United States), BGI Genomics Co., Ltd. (China), Eurofins Genomics (Germany), Macrogen Inc. (South Korea), Pacific Biosciences of California, Inc. (United States) and Swift Biosciences Inc. (United States)
CAGR%


Mergers and acquisitions, expansions, investments, new service launches, and collaborations are some of the companies' preferred market-exploration strategies. The company is contributing its share to increasing the company’s growth. The major key players like Illumina, Inc., Thermo Fisher Scientific, QIAGEN N.V., and PerkinElmer, Inc. are contributing their share to increasing the market growth.

Illumina, Inc. (United States), Thermo Fisher Scientific (United States), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (United States), Oxford Nanopore Technologies Plc. (United States), BGI Genomics Co., Ltd. (China), Eurofins Genomics (Germany), Macrogen Inc. (South Korea), Pacific Biosciences of California, Inc. (United States) and Swift Biosciences Inc. (United States) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Metagenomics Sequencing market by Type , by Application (Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biofuel and Others) and Region with country level break-up.

On the basis of geography, the market of Metagenomics Sequencing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In July 2021, QIAGEN N.V. (Netherlands) and Sysmex Corporation have forged a strategic agreement for the development and marketing of worldwide cancer companion diagnostics using NGS and Plasma-Safe-SeqS technology.
In Jan 2021, Illumina, Inc. (US) collaborated with Helix to strengthen national surveillance infrastructure in the US to track the emergence and prevalence of novel SARS-CoV-2 strains, with support from the CDC.


Influencing Trend:
Availability of Cloud Computing for Data Management

Market Growth Drivers:
New Technology Innovation in NGS Platform and Increasing Awareness Regarding Genetic Disorders

Challenges:
Challenges Associated With Metagenomics NGS and Strict Government Regulation in Market

Restraints:
Lack of Skilled Professionals Are Required and Budget Limits for End Users in Developing Nations

Opportunities:
Increasing Drug Manufactures In Developing Country and Increasing R&D Activities to Identify New Antibiotics and Enzymes Products

Key Target Audience
Industry Association, Downstream Vendors, Marketing & Consulting firms, Venture Capitalists, Government & Regulatory Bodies and Investors

Report Objectives / Segmentation Covered

By Application
  • Infectious Disease Diagnosis
  • Environmental Remediation
  • Gut Microbe Characterization
  • Biofuel
  • Others
By Technology
  • Sequencing
  • Bioinformatics

By Service
  • Reagents & Consumables
  • Metagenomics Sequencing Services
  • Analysis & Data Interpretation Solutions
  • Others

By Workflow
  • Sample Processing & Library Preparation
  • Sequencing
  • Data Processing & Analysis

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. New Technology Innovation in NGS Platform
      • 3.2.2. Increasing Awareness Regarding Genetic Disorders
    • 3.3. Market Challenges
      • 3.3.1. Challenges Associated With Metagenomics NGS
      • 3.3.2. Strict Government Regulation in Market
    • 3.4. Market Trends
      • 3.4.1. Availability of Cloud Computing for Data Management
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Metagenomics Sequencing, by Application, Technology, Service, Workflow and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Metagenomics Sequencing (Value)
      • 5.2.1. Global Metagenomics Sequencing by: Application (Value)
        • 5.2.1.1. Infectious Disease Diagnosis
        • 5.2.1.2. Environmental Remediation
        • 5.2.1.3. Gut Microbe Characterization
        • 5.2.1.4. Biofuel
        • 5.2.1.5. Others
      • 5.2.2. Global Metagenomics Sequencing by: Technology (Value)
        • 5.2.2.1. Sequencing
        • 5.2.2.2. Bioinformatics
      • 5.2.3. Global Metagenomics Sequencing by: Service (Value)
        • 5.2.3.1. Reagents & Consumables
        • 5.2.3.2. Metagenomics Sequencing Services
        • 5.2.3.3. Analysis & Data Interpretation Solutions
        • 5.2.3.4. Others
      • 5.2.4. Global Metagenomics Sequencing by: Workflow (Value)
        • 5.2.4.1. Sample Processing & Library Preparation
        • 5.2.4.2. Sequencing
        • 5.2.4.3. Data Processing & Analysis
      • 5.2.5. Global Metagenomics Sequencing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Metagenomics Sequencing (Price)
  • 6. Metagenomics Sequencing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Illumina, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. QIAGEN N.V. (Netherlands)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. PerkinElmer, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Oxford Nanopore Technologies Plc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BGI Genomics Co., Ltd. (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Eurofins Genomics (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Macrogen Inc. (South Korea)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Pacific Biosciences of California, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Swift Biosciences Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Metagenomics Sequencing Sale, by Application, Technology, Service, Workflow and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Metagenomics Sequencing (Value)
      • 7.2.1. Global Metagenomics Sequencing by: Application (Value)
        • 7.2.1.1. Infectious Disease Diagnosis
        • 7.2.1.2. Environmental Remediation
        • 7.2.1.3. Gut Microbe Characterization
        • 7.2.1.4. Biofuel
        • 7.2.1.5. Others
      • 7.2.2. Global Metagenomics Sequencing by: Technology (Value)
        • 7.2.2.1. Sequencing
        • 7.2.2.2. Bioinformatics
      • 7.2.3. Global Metagenomics Sequencing by: Service (Value)
        • 7.2.3.1. Reagents & Consumables
        • 7.2.3.2. Metagenomics Sequencing Services
        • 7.2.3.3. Analysis & Data Interpretation Solutions
        • 7.2.3.4. Others
      • 7.2.4. Global Metagenomics Sequencing by: Workflow (Value)
        • 7.2.4.1. Sample Processing & Library Preparation
        • 7.2.4.2. Sequencing
        • 7.2.4.3. Data Processing & Analysis
      • 7.2.5. Global Metagenomics Sequencing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Metagenomics Sequencing (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Metagenomics Sequencing: by Application(USD Million)
  • Table 2. Metagenomics Sequencing Infectious Disease Diagnosis , by Region USD Million (2018-2023)
  • Table 3. Metagenomics Sequencing Environmental Remediation , by Region USD Million (2018-2023)
  • Table 4. Metagenomics Sequencing Gut Microbe Characterization , by Region USD Million (2018-2023)
  • Table 5. Metagenomics Sequencing Biofuel , by Region USD Million (2018-2023)
  • Table 6. Metagenomics Sequencing Others , by Region USD Million (2018-2023)
  • Table 7. Metagenomics Sequencing: by Technology(USD Million)
  • Table 8. Metagenomics Sequencing Sequencing , by Region USD Million (2018-2023)
  • Table 9. Metagenomics Sequencing Bioinformatics , by Region USD Million (2018-2023)
  • Table 10. Metagenomics Sequencing: by Service(USD Million)
  • Table 11. Metagenomics Sequencing Reagents & Consumables , by Region USD Million (2018-2023)
  • Table 12. Metagenomics Sequencing Metagenomics Sequencing Services , by Region USD Million (2018-2023)
  • Table 13. Metagenomics Sequencing Analysis & Data Interpretation Solutions , by Region USD Million (2018-2023)
  • Table 14. Metagenomics Sequencing Others , by Region USD Million (2018-2023)
  • Table 15. Metagenomics Sequencing: by Workflow(USD Million)
  • Table 16. Metagenomics Sequencing Sample Processing & Library Preparation , by Region USD Million (2018-2023)
  • Table 17. Metagenomics Sequencing Sequencing , by Region USD Million (2018-2023)
  • Table 18. Metagenomics Sequencing Data Processing & Analysis , by Region USD Million (2018-2023)
  • Table 19. South America Metagenomics Sequencing, by Country USD Million (2018-2023)
  • Table 20. South America Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 21. South America Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 22. South America Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 23. South America Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 24. Brazil Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 25. Brazil Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 26. Brazil Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 27. Brazil Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 28. Argentina Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 29. Argentina Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 30. Argentina Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 31. Argentina Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 32. Rest of South America Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 33. Rest of South America Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 34. Rest of South America Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 35. Rest of South America Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 36. Asia Pacific Metagenomics Sequencing, by Country USD Million (2018-2023)
  • Table 37. Asia Pacific Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 38. Asia Pacific Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 39. Asia Pacific Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 40. Asia Pacific Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 41. China Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 42. China Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 43. China Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 44. China Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 45. Japan Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 46. Japan Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 47. Japan Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 48. Japan Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 49. India Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 50. India Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 51. India Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 52. India Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 53. South Korea Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 54. South Korea Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 55. South Korea Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 56. South Korea Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 57. Australia Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 58. Australia Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 59. Australia Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 60. Australia Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 61. Rest of Asia-Pacific Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 62. Rest of Asia-Pacific Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 65. Europe Metagenomics Sequencing, by Country USD Million (2018-2023)
  • Table 66. Europe Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 67. Europe Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 68. Europe Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 69. Europe Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 70. Germany Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 71. Germany Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 72. Germany Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 73. Germany Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 74. France Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 75. France Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 76. France Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 77. France Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 78. Italy Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 79. Italy Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 80. Italy Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 81. Italy Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 82. United Kingdom Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 83. United Kingdom Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 84. United Kingdom Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 85. United Kingdom Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 86. Netherlands Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 87. Netherlands Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 88. Netherlands Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 89. Netherlands Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 90. Rest of Europe Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 91. Rest of Europe Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 92. Rest of Europe Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 93. Rest of Europe Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 94. MEA Metagenomics Sequencing, by Country USD Million (2018-2023)
  • Table 95. MEA Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 96. MEA Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 97. MEA Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 98. MEA Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 99. Middle East Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 100. Middle East Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 101. Middle East Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 102. Middle East Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 103. Africa Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 104. Africa Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 105. Africa Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 106. Africa Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 107. North America Metagenomics Sequencing, by Country USD Million (2018-2023)
  • Table 108. North America Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 109. North America Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 110. North America Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 111. North America Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 112. United States Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 113. United States Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 114. United States Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 115. United States Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 116. Canada Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 117. Canada Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 118. Canada Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 119. Canada Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 120. Mexico Metagenomics Sequencing, by Application USD Million (2018-2023)
  • Table 121. Mexico Metagenomics Sequencing, by Technology USD Million (2018-2023)
  • Table 122. Mexico Metagenomics Sequencing, by Service USD Million (2018-2023)
  • Table 123. Mexico Metagenomics Sequencing, by Workflow USD Million (2018-2023)
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Metagenomics Sequencing: by Application(USD Million)
  • Table 135. Metagenomics Sequencing Infectious Disease Diagnosis , by Region USD Million (2025-2030)
  • Table 136. Metagenomics Sequencing Environmental Remediation , by Region USD Million (2025-2030)
  • Table 137. Metagenomics Sequencing Gut Microbe Characterization , by Region USD Million (2025-2030)
  • Table 138. Metagenomics Sequencing Biofuel , by Region USD Million (2025-2030)
  • Table 139. Metagenomics Sequencing Others , by Region USD Million (2025-2030)
  • Table 140. Metagenomics Sequencing: by Technology(USD Million)
  • Table 141. Metagenomics Sequencing Sequencing , by Region USD Million (2025-2030)
  • Table 142. Metagenomics Sequencing Bioinformatics , by Region USD Million (2025-2030)
  • Table 143. Metagenomics Sequencing: by Service(USD Million)
  • Table 144. Metagenomics Sequencing Reagents & Consumables , by Region USD Million (2025-2030)
  • Table 145. Metagenomics Sequencing Metagenomics Sequencing Services , by Region USD Million (2025-2030)
  • Table 146. Metagenomics Sequencing Analysis & Data Interpretation Solutions , by Region USD Million (2025-2030)
  • Table 147. Metagenomics Sequencing Others , by Region USD Million (2025-2030)
  • Table 148. Metagenomics Sequencing: by Workflow(USD Million)
  • Table 149. Metagenomics Sequencing Sample Processing & Library Preparation , by Region USD Million (2025-2030)
  • Table 150. Metagenomics Sequencing Sequencing , by Region USD Million (2025-2030)
  • Table 151. Metagenomics Sequencing Data Processing & Analysis , by Region USD Million (2025-2030)
  • Table 152. South America Metagenomics Sequencing, by Country USD Million (2025-2030)
  • Table 153. South America Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 154. South America Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 155. South America Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 156. South America Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 157. Brazil Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 158. Brazil Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 159. Brazil Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 160. Brazil Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 161. Argentina Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 162. Argentina Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 163. Argentina Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 164. Argentina Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 165. Rest of South America Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 166. Rest of South America Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 167. Rest of South America Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 168. Rest of South America Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 169. Asia Pacific Metagenomics Sequencing, by Country USD Million (2025-2030)
  • Table 170. Asia Pacific Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 171. Asia Pacific Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 172. Asia Pacific Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 173. Asia Pacific Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 174. China Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 175. China Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 176. China Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 177. China Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 178. Japan Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 179. Japan Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 180. Japan Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 181. Japan Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 182. India Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 183. India Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 184. India Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 185. India Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 186. South Korea Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 187. South Korea Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 188. South Korea Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 189. South Korea Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 190. Australia Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 191. Australia Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 192. Australia Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 193. Australia Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 194. Rest of Asia-Pacific Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 195. Rest of Asia-Pacific Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 196. Rest of Asia-Pacific Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 197. Rest of Asia-Pacific Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 198. Europe Metagenomics Sequencing, by Country USD Million (2025-2030)
  • Table 199. Europe Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 200. Europe Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 201. Europe Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 202. Europe Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 203. Germany Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 204. Germany Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 205. Germany Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 206. Germany Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 207. France Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 208. France Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 209. France Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 210. France Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 211. Italy Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 212. Italy Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 213. Italy Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 214. Italy Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 215. United Kingdom Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 216. United Kingdom Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 217. United Kingdom Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 218. United Kingdom Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 219. Netherlands Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 220. Netherlands Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 221. Netherlands Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 222. Netherlands Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 223. Rest of Europe Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 224. Rest of Europe Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 225. Rest of Europe Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 226. Rest of Europe Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 227. MEA Metagenomics Sequencing, by Country USD Million (2025-2030)
  • Table 228. MEA Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 229. MEA Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 230. MEA Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 231. MEA Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 232. Middle East Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 233. Middle East Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 234. Middle East Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 235. Middle East Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 236. Africa Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 237. Africa Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 238. Africa Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 239. Africa Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 240. North America Metagenomics Sequencing, by Country USD Million (2025-2030)
  • Table 241. North America Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 242. North America Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 243. North America Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 244. North America Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 245. United States Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 246. United States Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 247. United States Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 248. United States Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 249. Canada Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 250. Canada Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 251. Canada Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 252. Canada Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 253. Mexico Metagenomics Sequencing, by Application USD Million (2025-2030)
  • Table 254. Mexico Metagenomics Sequencing, by Technology USD Million (2025-2030)
  • Table 255. Mexico Metagenomics Sequencing, by Service USD Million (2025-2030)
  • Table 256. Mexico Metagenomics Sequencing, by Workflow USD Million (2025-2030)
  • Table 257. Research Programs/Design for This Report
  • Table 258. Key Data Information from Secondary Sources
  • Table 259. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Metagenomics Sequencing: by Application USD Million (2018-2023)
  • Figure 5. Global Metagenomics Sequencing: by Technology USD Million (2018-2023)
  • Figure 6. Global Metagenomics Sequencing: by Service USD Million (2018-2023)
  • Figure 7. Global Metagenomics Sequencing: by Workflow USD Million (2018-2023)
  • Figure 8. South America Metagenomics Sequencing Share (%), by Country
  • Figure 9. Asia Pacific Metagenomics Sequencing Share (%), by Country
  • Figure 10. Europe Metagenomics Sequencing Share (%), by Country
  • Figure 11. MEA Metagenomics Sequencing Share (%), by Country
  • Figure 12. North America Metagenomics Sequencing Share (%), by Country
  • Figure 13. Global Metagenomics Sequencing share by Players 2023 (%)
  • Figure 14. Global Metagenomics Sequencing share by Players (Top 3) 2023(%)
  • Figure 15. Global Metagenomics Sequencing share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Illumina, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Illumina, Inc. (United States) Revenue: by Geography 2023
  • Figure 19. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 20. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 21. QIAGEN N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 22. QIAGEN N.V. (Netherlands) Revenue: by Geography 2023
  • Figure 23. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. PerkinElmer, Inc. (United States) Revenue: by Geography 2023
  • Figure 25. Oxford Nanopore Technologies Plc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Oxford Nanopore Technologies Plc. (United States) Revenue: by Geography 2023
  • Figure 27. BGI Genomics Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 28. BGI Genomics Co., Ltd. (China) Revenue: by Geography 2023
  • Figure 29. Eurofins Genomics (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Eurofins Genomics (Germany) Revenue: by Geography 2023
  • Figure 31. Macrogen Inc. (South Korea) Revenue, Net Income and Gross profit
  • Figure 32. Macrogen Inc. (South Korea) Revenue: by Geography 2023
  • Figure 33. Pacific Biosciences of California, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Pacific Biosciences of California, Inc. (United States) Revenue: by Geography 2023
  • Figure 35. Swift Biosciences Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Swift Biosciences Inc. (United States) Revenue: by Geography 2023
  • Figure 37. Global Metagenomics Sequencing: by Application USD Million (2025-2030)
  • Figure 38. Global Metagenomics Sequencing: by Technology USD Million (2025-2030)
  • Figure 39. Global Metagenomics Sequencing: by Service USD Million (2025-2030)
  • Figure 40. Global Metagenomics Sequencing: by Workflow USD Million (2025-2030)
  • Figure 41. South America Metagenomics Sequencing Share (%), by Country
  • Figure 42. Asia Pacific Metagenomics Sequencing Share (%), by Country
  • Figure 43. Europe Metagenomics Sequencing Share (%), by Country
  • Figure 44. MEA Metagenomics Sequencing Share (%), by Country
  • Figure 45. North America Metagenomics Sequencing Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Illumina, Inc. (United States)
  • Thermo Fisher Scientific (United States)
  • QIAGEN N.V. (Netherlands)
  • PerkinElmer, Inc. (United States)
  • Oxford Nanopore Technologies Plc. (United States)
  • BGI Genomics Co., Ltd. (China)
  • Eurofins Genomics (Germany)
  • Macrogen Inc. (South Korea)
  • Pacific Biosciences of California, Inc. (United States)
  • Swift Biosciences Inc. (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 236 Pages 50 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Metagenomics Sequencing Quantitative research analysis
Global Metagenomics Sequencing Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Metagenomics Sequencing Market are by end use application [Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biofuel and Others].
The Metagenomics Sequencing Market is gaining popularity and expected to see strong valuation by 2030.
  • New Technology Innovation in NGS Platform
  • Increasing Awareness Regarding Genetic Disorders

Know More About Global Metagenomics Sequencing Report?

Have a Query? Click Here

Other Related Reports

Atosiban Comprehensive Study by Type (Injection, Concentrate), Application (Suppression of Preterm Labour, Others), End User (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to...
$ 3500
Pathogen Identification and Treatment Comprehensive Study by Type (Denaturation, Annealing, Amplification, Detection), Application (Biodefense, Animal Health Care, Food Safety, Diagnostics, Pathology...
$ 3350
Pulmonary Surfactant Comprehensive Study by Type (Synthetic Pulmonary Surfactants, Animal Derived Surfactants), Application (Hospital, Laboratory, Others), End User (Adults, Children) Players and Reg...
$ 3500
Cancer Supportive Care Drugs Comprehensive Study by Application (Chemotherapy Therapy, Radiation Therapy), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies), Cance...
$ 3750
Botanical and Plant Derived Drugs Comprehensive Study by Type (Tablets, Capsules, Pills, Injections), Application (Central Nervous System, Cardiovascular Diseases, Infectious Diseases, Respiratory Di...
$ 3750
Ashwagandha Extract Comprehensive Study by Application (Sports Nutrition, Food & Beverages, Dietary Supplements, Other), Source (Root, Leaves, Others), Extract Percentage (Ashwagandha Extract 1.5%, ...
$ 3650